» Articles » PMID: 8272873

Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 Beta Receptor Components

Overview
Journal Science
Specialty Science
Date 1994 Jan 7
PMID 8272873
Citations 246
Authors
Affiliations
Soon will be listed here.
Abstract

A recently defined family of cytokines, consisting of ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), and interleukin-6 (IL-6), utilize the Jak-Tyk family of cytoplasmic tyrosine kinases. The beta receptor components for this cytokine family, gp130 and LIF receptor beta, constitutively associate with Jak-Tyk kinases. Activation of these kinases occurs as a result of ligand-induced dimerization of the receptor beta components. Unlike other cytokine receptors studied to date, the receptors for the CNTF cytokine family utilize all known members of the Jak-Tyk family, but induce distinct patterns of Jak-Tyk phosphorylation in different cell lines.

Citing Articles

Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis.

Romo B, Fuentes Z, Randolph L, Mahajan M, Aller E, Ebrahimi B Cancers (Basel). 2025; 17(5).

PMID: 40075639 PMC: 11898489. DOI: 10.3390/cancers17050790.


The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis.

Komaki S, Inagaki T, Kumar A, Izumiya Y Viruses. 2025; 16(12.

PMID: 39772207 PMC: 11680145. DOI: 10.3390/v16121900.


Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes.

Zhou Y, Stevis P, Cao J, Ehrlich G, Jones J, Rafique A Nat Commun. 2024; 15(1):9776.

PMID: 39532904 PMC: 11557873. DOI: 10.1038/s41467-024-54124-1.


Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer.

Randolph L, Joshi J, Sanchez A, Pratap U, Gopalam R, Chen Y Cancers (Basel). 2024; 16(21).

PMID: 39518071 PMC: 11545110. DOI: 10.3390/cancers16213630.


Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.

Ebrahimi B, Viswanadhapalli S, Pratap U, Rahul G, Yang X, Pitta Venkata P NPJ Precis Oncol. 2024; 8(1):118.

PMID: 38789520 PMC: 11126619. DOI: 10.1038/s41698-024-00612-y.